Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet therapy for controlling HIV infection. This drug combines three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the HIV's ability to multiply within the body, remarkably lowering the viral load. For many ind